Literature DB >> 21658146

Effect of warfarin on menstruation and menstrual management of the adolescent on warfarin.

Lyndal J Peake1, Sonia R Grover, Paul T Monagle, Andrew D Kennedy.   

Abstract

AIM: The aim of this study was to review a consecutive cohort of adolescent females on warfarin to determine the effect of warfarin on menstruation, management options and their perceived efficacy.
METHODS: All female patients on warfarin, over the age of 10 years, as of 31 August 2006, were identified using the Department of Haematology (Royal Children's Hospital) warfarin database. The presence of menorrhagia was defined by clinical indicators.
RESULTS: Of 81 adolescent females on warfarin, 24 (30%) were referred to gynaecology due to a concern about heavy periods and one for anticipatory guidance, on the basis of impending menarche. In 18 cases (22% of the cohort), menorrhagia could be substantiated on the basis of clinical indicators. Nineteen patients required treatment for menorrhagia with the options for treatment being the combined oral contraceptive pill, subdermal hormone administrations, tranexamic acid and the progesterone-only contraceptive pill. Significant adolescent psychosocial stresses were identified in those adolescents taking warfarin.
CONCLUSIONS: Adolescent females on warfarin commonly suffer from menorrhagia. Adolescent review of all teenage girls receiving warfarin therapy is indicated.
© 2011 The Authors. Journal of Paediatrics and Child Health © 2011 Paediatrics and Child Health Division (Royal Australasian College of Physicians).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21658146     DOI: 10.1111/j.1440-1754.2011.02101.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  5 in total

1.  Evaluation of cerebral venous thrombosis secondary to oral contraceptive use in adolescents.

Authors:  Hasan H Özdemir; Sefer Varol; Eşref Akıl; Abdullah Acar; Caner F Demir
Journal:  Neurol Sci       Date:  2014-08-05       Impact factor: 3.307

2.  Heavy menstrual bleeding in women on anticoagulant treatment for venous thromboembolism: Comparison of high- and low-dose rivaroxaban with aspirin.

Authors:  Kochawan Boonyawat; Anthonie W A Lensing; Martin H Prins; Jan Beyer-Westendorf; Paolo Prandoni; Ida Martinelli; Saskia Middeldorp; Akos F Pap; Jeffrey I Weitz; Mark Crowther
Journal:  Res Pract Thromb Haemost       Date:  2021-02-17

3.  Menstrual Dysfunction and Treatment Among Adolescents With Congenital Heart Disease.

Authors:  Maayan Leroy-Melamed; Amy Katz; Marcia L Shew
Journal:  J Pediatr Adolesc Gynecol       Date:  2020-08-20       Impact factor: 2.046

Review 4.  Sex matters: Practice 5P's when treating young women with venous thromboembolism.

Authors:  Ingrid M Bistervels; Luuk J J Scheres; Eva N Hamulyák; Saskia Middeldorp
Journal:  J Thromb Haemost       Date:  2019-07-23       Impact factor: 5.824

5.  A quality-of-life questionnaire for heavy menstrual bleeding in Thai women receiving oral antithrombotics: Assessment of the translated Menstrual Bleeding Questionnaire.

Authors:  Tinaram Rodpetch; Jittima Manonai; Pantep Angchaisuksiri; Kochawan Boonyawat
Journal:  Res Pract Thromb Haemost       Date:  2021-11-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.